@MaartenvSmeden Yeah that's why the first word is tiny. But I'm tweeting each one I see. The large completed trials not showing benefit, tho a small IVIG trial has https://t.co/59VG1N0xWb. No or negligible benefit would be consistent with trial evidence be
@DrMJoyner @matthewherper @hartman_bill @HollyLynchez @ACasadevall1 Maybe, if benefit is found - and that was never by any means guaranteed https://t.co/qnyqnDOOCd. Sounds like it's now just a question of how much of "the mosaic" will be tiled with tragedy
RT @hildabast: @zbysfedo Still no strong favorable RCT data. NIH trials for it with influenza found no benefit. https://t.co/VBdgObuAAR Jul…
@zbysfedo Still no strong favorable RCT data. NIH trials for it with influenza found no benefit. https://t.co/VBdgObuAAR July sysrev concluding minimal or no benefit for Covid-19 was likely: https://t.co/qnyqnDOOCd Onus really is on any good RCT counteract
@jjcouey @WIRED And that sort of thinking is exactly why so many doctors & patients will use plasma, when it's not the theoretical basis that matters, but whether it works in trials. And so far, it hasn't for any other disease: https://t.co/qnyqnDOOCd
RT @cdavidnaylor: Oscar: More POTUS 💩tonight? Not-Dog: Yep. Likely a decree on pooled plasma. Oscar: Posturing? ND: Yep. Already has FDA…
RT @cdavidnaylor: Oscar: More POTUS 💩tonight? Not-Dog: Yep. Likely a decree on pooled plasma. Oscar: Posturing? ND: Yep. Already has FDA…
@SilasDogood8 @ATXmetalgod https://t.co/O1STGvpnqb Doctors havent demonstrated strong statistically significant overall benefit yet. And I agree with you. We should listen to the Doctors that study this and not Politicians.
@MarianRosin @PressSec @realDonaldTrump Studies have been underway around the world investigating the efficacy and safety of the use of convalescent plasma in treating SARS-CoV-2 since the spring. This circumvents the need for full FDA approval, and might
RT @georgezab: @WhiteHouse @realDonaldTrump Canadian studies find no benefit. Trump is selling snake oil again to save his political ass.…
Studies of non-COVID-19 severe respiratory viral infections provide indirect, very low-quality evidence that raises the possibility that convalescent plasma has minimal or no benefit in the treatment of COVID-19 ...https://t.co/9PkBaUbrfj
@DaveCashInvest @NorthmanTrader https://t.co/STemcxYNzI Convalescent plasma don't do much.
@RESachs @gregggonsalves https://t.co/STemcxYNzI This is what convalescence plasma does. Not a big deal in my opinion.
@stoolpresidente https://t.co/STemcxYNzI Not the big deal in my opinions. But yes it will be bull.
RT @cdavidnaylor: Oscar: More POTUS 💩tonight? Not-Dog: Yep. Likely a decree on pooled plasma. Oscar: Posturing? ND: Yep. Already has FDA…
RT @cdavidnaylor: Oscar: More POTUS 💩tonight? Not-Dog: Yep. Likely a decree on pooled plasma. Oscar: Posturing? ND: Yep. Already has FDA…
Oscar: More POTUS 💩tonight? Not-Dog: Yep. Likely a decree on pooled plasma. Oscar: Posturing? ND: Yep. Already has FDA emerg authoriz'n. Many RCTs underway. Confusing picture: https://t.co/eiazwTH4B3 So we need those results. Oscar: So, this is all abou
RT @sandi89701936: Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infec…
Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis | CMAJ https://t.co/uNKI5vrNiR
RT @RevistaMFSamfyc: Eficacia y seguridad del plasma de convalecientes para la COVID-19 grave basadas en la evidencia de otras infecciones…
Eficacia y seguridad del plasma de convalecientes para la COVID-19 grave basadas en la evidencia de otras infecciones respiratorias víricas graves: revisión sistemática y metaanálisis https://t.co/mHGPTxAQxe PMID 32444482
New2Trip: Efficacy & safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: systematic review & meta-analysis https://t.co/iVEsg8K0X1
RT @prat1112001: Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infecti…
RT @prat1112001: Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infecti…
Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis https://t.co/IMrDOMdN2M
RT @tripdatabase: New2Trip: Efficacy & safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory vira…
New2Trip: Efficacy & safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: systematic review & meta-analysis https://t.co/iVEsg8K0X1
Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis https://t.co/IMrDOMdN2M
RT @marcelo_zapata: @sebasugarte No, eso es mala ciencia Dr. https://t.co/1WmShNxGgF
RT @marcelo_zapata: @sebasugarte No, eso es mala ciencia Dr. https://t.co/1WmShNxGgF
@sebasugarte No, eso es mala ciencia Dr. https://t.co/1WmShNxGgF
RT @rincondesisifo: (CMAJ) Seguridad y eficacia del plasma de convalesciente en pac graves con #COVID19 en base a la evidencia procedente d…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia del plasma de convalesciente en pac graves con #COVID19 en base a la evidencia procedente d…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia del plasma de convalesciente en pac graves con #COVID19 en base a la evidencia procedente d…
(CMAJ) Seguridad y eficacia del plasma de convalesciente en pac graves con #COVID19 en base a la evidencia procedente de otras infecciones respiratorias víricas https://t.co/dDT00qzPT8 Rev Sist y MA https://t.co/XhQUdezmFN
RT @tripdatabase: New2Trip: Efficacy & safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory vira…
New2Trip: Efficacy & safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: systematic review & meta-analysis https://t.co/iVEsg8K0X1
New2Trip: Efficacy & safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: systematic review & meta-analysis https://t.co/iVEsg8K0X1
RT @FundacioICF: Revisió sistemàtica i metanàlisi. Inclou 6 estudis. Cap pacient amb #COVID19 Proves febles i de poca qualitat. Benefici in…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia del plasma de convaleciente en el tto del #COVID19 grave https://t.co/ZKw67i31jW Rev Sist y…
RT @FundacioICF: Revisió sistemàtica i metanàlisi. Inclou 6 estudis. Cap pacient amb #COVID19 Proves febles i de poca qualitat. Benefici in…
RT @FundacioICF: Revisió sistemàtica i metanàlisi. Inclou 6 estudis. Cap pacient amb #COVID19 Proves febles i de poca qualitat. Benefici in…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia del plasma de convaleciente en el tto del #COVID19 grave https://t.co/ZKw67i31jW Rev Sist y…
Revisió sistemàtica i metanàlisi. Inclou 6 estudis. Cap pacient amb #COVID19 Proves febles i de poca qualitat. Benefici incert
RT @rincondesisifo: (CMAJ) Seguridad y eficacia del plasma de convaleciente en el tto del #COVID19 grave https://t.co/ZKw67i31jW Rev Sist y…
(CMAJ) Seguridad y eficacia del plasma de convaleciente en el tto del #COVID19 grave https://t.co/ZKw67i31jW Rev Sist y MA https://t.co/6tqfNlmiX4
Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19 – via @CMAJ https://t.co/HAKXTJN7tA
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
.@mcmasternpc's @RachelCouban is an author on this new paper about COVID-19. https://t.co/5YgjUR62Ge
RT @sakir_rheum: #COVID__19 has no magic bullet yet. #immune therapies maybe over subscribed! https://t.co/WoklBVNNQF
#COVID__19 has no magic bullet yet. #immune therapies maybe over subscribed!
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @pablolavados: Necesitamos que todos los pacientes que reciban esta terapia, estén en un ensayo clínico
@patoricky3 @RCastro_L @AndreaObaid Eficaz? Necesitamos más y mejor evidencia para afirmar eso. https://t.co/7yM9Nxxd9b
@RCastro_L Hay que ser humildes y científicos. Necesitamos más evidencia.. https://t.co/7yM9Nxxd9b
Necesitamos que todos los pacientes que reciban esta terapia, estén en un ensayo clínico
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @Rudra_P_Goswami: Finally somebody is pulling the curtain on this nonsense of 'Hollywood' medicine... https://t.co/k9HfIAE4Lk
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
@RCastro_L Estimado Dr. Las 2 Rev + recientes (metodología GRADE y Cochrane) respaldan los dichos del Ministro. "We identified very low-certainty evidence on the effectiveness and safety of convalescent plasma therapy for people with COVID-19" https://t.co
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @Rudra_P_Goswami: Finally somebody is pulling the curtain on this nonsense of 'Hollywood' medicine...
Finally somebody is pulling the curtain on this nonsense of 'Hollywood' medicine...
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
Not very promising that reconvalescent plasma may be efficacious, but obviously we need the trials that are currently under way for the final answer.
RT @MacDeptMed: Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convale…
Dr. Mark Loeb, Division Director of Infectious Diseases, et. al. conducted a systematic review and meta-analysis of convalescent plasma in #COVIDー19 and other severe respiratory viral infections. Full paper: https://t.co/yXNJvqc5hV https://t.co/13LRQ8C2vD
RT @VirologyConsult: Efficacy and Safety of Convalescent Plasma for Severe COVID-19 Based on Evidence in Other Severe Respiratory Viral Inf…
Efficacy and Safety of Convalescent Plasma for Severe COVID-19 Based on Evidence in Other Severe Respiratory Viral Infections: A Systematic Review and Meta-Analysis https://t.co/EVbXOSTohQ
New article: Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis. https://t.co/rqLJIfCpje #coronavirus #COVID19 #2019ncov https://t.co/eJARsfk0
Convalescent plasma therapy may have little benefit in #COVID19 treatment based on clinical evidence from its use in other severe viral respiratory illnesses: https://t.co/BQmmy7hlBg @MLRGresearch #hematology #immunology #coronavirus https://t.co/KFtvYo161